Active

BIOWIN

Switched

BE0882768591

Rechtspersoon Non-profit association 1 establishment

Avenue d'Ecolys(RH) 2, 5020 Namur Activiteiten van bedrijfs- en werkgeversorganisaties

Active for

20 year, 1 month

Financials

Financial year 2025

Worth noting

  • Figures corrected afterwards (2023).

Gross margin

€ 1.1 million

▲ 28% vs 2024

Profit

Caution

€ -13,428

▼ 143% vs 2024

Debts

Normal

€ 834,654

▼ 29% vs 2024

BIOWIN from Namur, company number BE0882768591, closed financial year 2025 with a result of € -13,428 after tax. For that financial year BIOWIN recorded a gross margin of € 1.1 million and equity of € 300,808. Compared with financial year 2024, the result moved from € 31,577 to € -13,428. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What happened at BIOWIN?

What happened at BIOWIN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 13,428 (▼ 143% vs 2024). Source: NBB ↗
  • EYED PHARMA stepped down as director. NBB
  • ION BEAN APPLICATIONS stepped down as director. NBB
  • COMMUNICARE SA stepped down as director. NBB
  • CER-GROUPE stepped down as director. NBB
  • UNIVERSITE DE NAMUR stepped down as director. NBB
  • EXO BIOLOGICS stepped down as director. NBB
  • GSK stepped down as director. NBB

In short

From € 121,480 profit in 2021 to € 13,428 loss in 2025.

Paid € 7,972 in corporate taxes since 2021.

Best year ever: 2021, with € 121,480 profit.

On average € 139,800 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at BIOWIN? We notify you, reason included.

Follow BIOWIN

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Directors

According to the 2025 annual accounts

EYED PHARMA

Director · represented by MELANIE MESTDAGT

since 2023 · until 2026

ION BEAN APPLICATIONS

Director · represented by Cristiana Gameiro-Paris

Also active at: SOCIETE D'INVESTISSEMENT ET DE FINANCEMENT DU BRABANT WALLON, Lease.BW, B2START +2 more

since 2025 · until 2026

COMMUNICARE SA

Director · represented by ALFRED ATTIPOE

since 2023 · until 2026

CER-GROUPE

Director · represented by OLIVIER VANLOOCKE

since 2023 · until 2026

UNIVERSITE DE NAMUR

Director · represented by CARINE MICHIELS

Also active at: CENTRE D'EXCELLENCE EN TECHNOLOGIES DE L'INFORMATION ET DE LA COMMUNICATION, TECHNO.BEL, UNIVERSITE OUVERTE DE LA FEDERATION WALLONIE-BRUXELLES +2 more

since 2023 · until 2026

EXO BIOLOGICS

Director · represented by HUGUES WALLEMACQ

since 2023 · until 2026

GSK

Director · represented by PHILIPPE DENOEL

since 2023 · until 2026

ULB

Director · represented by SERGE SCHIFFMANN

Also active at: HUmani, La Fonderie, TECHNOFUTUR TIC +5 more

since 2023 · until 2026

ACADEMIE UNIVERSITAIRE LOUVAIN

Director · represented by JEAN-CHRISTOPHE RENAULD

Also active at: CESI, Centre indépendant de Promotion fourragère - Onafhankelijk Groenvoeder Centrum, Centre d'Information de l'Architecture, de l'Urbanisme et du Design-Informatiecentrum voor Architectuur, Stedebouw en Design +15 more

since 2023 · until 2026

ULG

Director · represented by BRIGITTE MALGRANGE

Also active at: Observatoire de l'Intégration

since 2023 · until 2026

NOVADIP

Director · represented by Denis Dufrane

since 2025 · until 2026

UNIVERSITE DE MONS

Director · represented by ANNE-EMILIE DECLEVES

Also active at: MAISON DE L'ENTREPRISE, Centre Européen d'Entreprise et d'Innovation (CEEI), TECHNOCITE, Brussels South Charleroi BioPark Dev +3 more

since 2023 · until 2026

TELIX PHARMACEUTICALS

Director · represented by Sébastien Linard

since 2025 · until 2026

KANEKA EUROGENTEC

Director · represented by FLORENCE XHONNEUX

since 2023 · until 2026

UCB

Director · represented by Xavier Hormaechea

Also active at: ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE

since 2023 · until 2026

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue d'Ecolys(RH) 2 box 29

5020 Namur

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 73 companies are registered at this address.

Etablissements Auguste Defoux

€ 55,269 gross margin · 2025

CELORD

€ 27,447 gross margin · 2025

A.A.S.V.

€ 2.6 million gross margin · 2024

DEBUT

€ 443,180 gross margin · 2025

ISMANARA

€ 904,944 gross margin · 2025

+68 more

Details

Company number
0882.768.591
VAT number
BE 0882.768.591
Registered office
Avenue d'Ecolys(RH) 2 bus 29, 5020 Namur
Names & denominations
BIOWIN
Enterprise type
Rechtspersoon
Legal form
Non-profit association
Legal situation
Normale toestand
Start date
28 July 2006
Peppol
Active · Active since 19 Dec 2025
Activities · NACE

Activiteiten van bedrijfs- en werkgeversorganisaties

Bedrijfs- en werkgeversorganisaties

Overige zakelijke dienstverlening, neg

Overige zakelijke dienstverlening, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What is the enterprise number of BIOWIN?
The enterprise number of BIOWIN is BE0882768591.
What is the address of BIOWIN?
The registered office of BIOWIN is located at Avenue d'Ecolys(RH) 2 box 29, 5020 Namur.
When was BIOWIN founded?
BIOWIN was founded on 28 July 2006.
What is the main activity of BIOWIN?
The main activity of BIOWIN is "Activiteiten van bedrijfs- en werkgeversorganisaties" (NACE code 94110).
Does BIOWIN have a website?
No website is currently known for BIOWIN.
How much profit did BIOWIN make in 2025?
BIOWIN recorded a loss after taxes of € 13,428 in financial year 2025.
What is the revenue of BIOWIN?
As a small company, BIOWIN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,062,704.
How many employees does BIOWIN have?
According to the 2025 annual accounts, BIOWIN has 7.6 full-time equivalents (FTE).
Where can I find the annual accounts of BIOWIN?
BIOWIN files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of BIOWIN?
According to the 2025 annual accounts, the directors of BIOWIN are: EYED PHARMA, ION BEAN APPLICATIONS, COMMUNICARE SA, CER-GROUPE, UNIVERSITE DE NAMUR, EXO BIOLOGICS, GSK, ULB.